MAPT and Alzheimer disease: Using synthetic peptides, it is confirmed that CP13 recognizes tau phosphorylated at Ser202 and not Ser199 or Thr205, but in addition phosphorylation at both Ser199 and Thr205 do not interfere with CP13 binding which is also probably because this antibody was also raised against PHF-tau from AD brains [82].